American Society of Hematology

SHERPA: Blue

People

  1. Scheinberg
    Scheinberg
  2. Berman
    Berman
  3. Mcdevitt
    Mcdevitt
  4. Caron
    Caron
  5. Park
    Park
  6. Tallman
    Tallman
  7. Bernal
    Bernal
  8. Dao
    Dao
  9. Panageas
    Panageas
  10. Ballangrud-Popovic
    Ballangrud-Popovic

Groups

  1. Department of Medicine (48)
  2. Hematologic Malignancies, Division of (48)
  3. Adult Leukemia (45)
  4. Center for Hematologic Malignancies (45)
  5. GSK Faculty (39)
  6. Hematologic Malignancies Research (38)
  7. Center for Molecular Imaging and Biotechnology (CMIB) (32)
  8. Molecular Pharmacology and Chemistry Program Faculty (32)
  9. Sloan Kettering Institute Faculty (32)
  10. Tow Center for Developmental Oncology (TCDO) (32)
Search Within
  1. "Joseph Jurcic"
Formats
  1. Meeting Abstract (40)
  2. Journal Article (8)
Groups
  1. Department of Medicine (48)
  2. Hematologic Malignancies, Division of (48)
  3. Adult Leukemia (45)
  4. Center for Hematologic Malignancies (45)
  5. GSK Faculty (39)
  6. Hematologic Malignancies Research (38)

More Groups

People
  1. Joseph Jurcic (48)
  2. David Scheinberg (31)
  3. Peter Maslak (23)
  4. Mark Frattini (15)
  5. Mark Heaney (15)
  6. Mark Weiss (13)

More People

Years
  1. 2018 (1)
  2. 2012 (6)
  3. 2011 (6)
  4. 2010 (4)
  5. 2009 (2)
  6. 2008 (2)

More Years

Publications
  1. Blood (47)
  2. Blood Advances (1)

Results (48)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia
    Journal Article

    Maslak, P. G.; Dao, T.; Bernal, Y.; Chanel, S. M.; Zhang, R.; Frattini, M.; Rosenblat, T.; Jurcic, J. G.; Brentjens, R. J.; Arcila, M. E.; more...
    Blood Advances (2018)

    Fulltext@MSK | Save
  • Phase II trial of WT1 analog peptide vaccine in patients with acute myeloid leukemia (AML) in complete remission (CR)
    Meeting Abstract

    Rosenblat, T. L.; Frattini, M. G.; Chanel, S. M.; Dao, T.; Bernal, Y.; Jurcic, J. G.; Zhang, R.; Simancek, P.; Tallman, M. S.; Scheinberg, D. A.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • High dose cytarabine and mitoxantrone in combination with dasatinib as active induction therapy in adult patients with Philadelphia chromosome positive (ph plus ) acute lymphoblastic leukemia (ALL)
    Meeting Abstract

    Lamanna, N.; Weiss, M.; Berman, E.; Frattini, M. G.; Heaney, M.; Jurcic, J. G.; Rosenblat, T. L.; Landau, H.; Weissbrot, H.; Maslak, P. G.
    Blood (2012)

    Fulltext@MSK | Save
  • Micafungin versus posaconazole anti-fungal prophylaxis in adult patients with acute leukemia undergoing induction chemotherapy
    Meeting Abstract

    Halton, E.; Chung, D.; Xiao, K.; Quintanilla, H.; Baldwin, C.; Baird, P.; Berman, E.; Brentjens, R. J.; Heaney, M.; Jurcic, J. G.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Aerobic glycolysis predicts outcome in early chronic lymphocytic leukemia
    Meeting Abstract

    Gardner, J. R.; Devlin, S.; Knapp, K.; Bauli, F.; Lamanna, N.; Frattini, M. G.; Brentjens, R. J.; Maslak, P. G.; Jurcic, J. G.; Weiss, M.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Molecular remission and B cell aplasia induced in a first cohort of adults with relapsed B-ALL treated with 19-28z CAR-targeted T cells
    Meeting Abstract

    Davila, M. L.; Riviere, I.; Wang, X. Y.; Park, J. H.; Stefanski, J.; Taylor, C.; He, Q.; Olszewska, M.; Wasielewska, T.; Borquez-Ojeda, O.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Outcome of stem cell transplantation in adults with acute myelogenous leukemia and normal cytogenetics (NC-AML) according to presence of FLT-3 internal tandem duplication (FLT-3ITD) at the time of diagnosis
    Meeting Abstract

    Berman, E.; Jakubowski, A. A.; Maloy, M.; Jurcic, J. G.; Jhanwar, S. C.; Hedvat, C. V.; Giralt, S.; Papadopoulos, E. B.
    Blood (2012)

    Fulltext@MSK | Save
  • Lintuzumab and low-dose cytarabine compared to placebo and low-dose cytarabine in patients with untreated acute myeloid leukemia (AML) 60 years and older: Results of a randomized, double-blinded phase 2b study
    Meeting Abstract

    Lancet, J. E.; Sekeres, M. A.; Wood, B. L.; Grove, L. E.; Sandalic, L.; Sievers, E. L.; Jurcic, J. G.
    Blood (2011)

    Fulltext@MSK | Save
  • Phase I trial of the targeted alpha-particle nano-generator actinium-225 (ac-225)-lintuzumab (anti-CD33; HuM195) in acute myeloid leukemia (AML)
    Meeting Abstract

    Jurcic, J. G.; Rosenblat, T. L.; McDevitt, M. R.; Pandit-Taskar, N.; Carrasquillo, J. A.; Chanel, S. M.; Zikaras, K.; Frattini, M. G.; Maslak, P. G.; Cicic, D.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Elevated mitochondrial membrane potential in CLL cells is associated with a more aggressive natural history
    Meeting Abstract

    Gardner, J. R.; Knapp, K.; Frattini, M. G.; Lamanna, N.; Brentjens, R.; Jurcic, J. G.; Maslak, P. G.; Berman, E.; Weiss, M.; Scheinberg, D. A.; more...
    Blood (2011)

    Fulltext@MSK | Save